Advent Pharma Ltd. (DSE: ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 16.80
+0.10 (0.60%)
At close: Dec 19, 2024
Advent Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2016 |
| Net Income | 66.62 | 83.99 | 98.64 | 97.53 | 113.59 | 117.05 | Upgrade
|
| Depreciation & Amortization | 66.04 | 66.51 | 59.18 | 42.27 | 38.75 | 33.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | 29.61 | 29.61 | 0.02 | - | 0.39 | - | Upgrade
|
| Other Operating Activities | 24.36 | 29.68 | 38.47 | 38.36 | 24.42 | 44.01 | Upgrade
|
| Change in Accounts Receivable | -24.56 | -16.32 | -10.32 | -2.15 | 4.21 | -39.39 | Upgrade
|
| Change in Inventory | 16.16 | 12.51 | 0.78 | -5.12 | -7.53 | 2.92 | Upgrade
|
| Change in Accounts Payable | -2.42 | -10.96 | 10.83 | 1.08 | -1.31 | 4.89 | Upgrade
|
| Change in Other Net Operating Assets | -25.33 | -19.89 | 7.7 | 7.6 | 7.86 | 6.91 | Upgrade
|
| Operating Cash Flow | 150.46 | 175.13 | 205.3 | 179.57 | 180.38 | 170.1 | Upgrade
|
| Operating Cash Flow Growth | -26.11% | -14.69% | 14.33% | -0.45% | 6.05% | -16.84% | Upgrade
|
| Capital Expenditures | -134.16 | -162.06 | -202.73 | -191.13 | -184.06 | -212.42 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.7 | 2.7 | 0.68 | - | 0.23 | - | Upgrade
|
| Investment in Securities | - | - | - | 40 | - | 40 | Upgrade
|
| Investing Cash Flow | -131.46 | -159.36 | -202.06 | -151.13 | -183.83 | -172.42 | Upgrade
|
| Short-Term Debt Issued | - | 5.01 | 11.72 | 6.44 | 13.47 | 16.12 | Upgrade
|
| Total Debt Issued | -0.9 | 5.01 | 11.72 | 6.44 | 13.47 | 16.12 | Upgrade
|
| Long-Term Debt Repaid | - | -0.59 | -4.04 | -4.2 | -2.59 | -3.23 | Upgrade
|
| Total Debt Repaid | -0.6 | -0.59 | -4.04 | -4.2 | -2.59 | -3.23 | Upgrade
|
| Net Debt Issued (Repaid) | -1.5 | 4.42 | 7.68 | 2.25 | 10.88 | 12.89 | Upgrade
|
| Common Dividends Paid | -7.09 | -8.2 | -8.81 | -22.22 | -8.08 | -8.71 | Upgrade
|
| Other Financing Activities | -12.31 | -9.1 | -5.35 | -6.84 | -3.01 | -4.25 | Upgrade
|
| Financing Cash Flow | -20.89 | -12.88 | -6.48 | -26.82 | -0.21 | -0.08 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | -1.89 | 2.89 | -3.24 | 1.63 | -3.65 | -2.4 | Upgrade
|
| Free Cash Flow | 16.3 | 13.08 | 2.56 | -11.56 | -3.67 | -42.33 | Upgrade
|
| Free Cash Flow Growth | 102.06% | 409.89% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 3.12% | 2.29% | 0.46% | -2.18% | -0.73% | -7.93% | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.14 | 0.03 | -0.12 | -0.04 | -0.45 | Upgrade
|
| Cash Interest Paid | 12.31 | 9.1 | 5.35 | 6.83 | 3.01 | 4.23 | Upgrade
|
| Cash Income Tax Paid | 2 | 2.86 | 3.08 | 2.36 | 3.9 | 6.62 | Upgrade
|
| Levered Free Cash Flow | -30.56 | -36.41 | -44.03 | -68.27 | -56.36 | -103.46 | Upgrade
|
| Unlevered Free Cash Flow | -25.25 | -31.35 | -39.89 | -65.7 | -53.3 | -100.68 | Upgrade
|
| Change in Net Working Capital | 31.88 | 24.34 | -19.06 | 0.21 | -6.74 | 19.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.